Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from an analysis of 160 real-world patients with ...
Get key insights from Myriad Genetics’ Q3 2025 earnings call, growth strategies, financial outlook, and new product launches.
News-Medical.Net on MSN
New approach harnesses tumor's own machinery to produce immune-stimulating molecules
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
The immune/tumor microenvironment significantly influences cancer progression and the efficacy of immunotherapeutic ...
The field of oncology has been profoundly impacted by malignant solid tumours, representing a significant challenge in healthcare. While strides have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback